This educational activity is based on a symposium offered in conjunction with the Oncology Nursing Society’s 29th Annual Congress.
Faculty
|
Barbara A. Barhamand, MS, RN, AOCN Oncology Clinical Nurse Specialist/Practice Manager Hematology Oncology Consultants, Ltd Naperville, Illinois |
Cheryl D. Kosits, MSN, RN, OCN, CCRC Supervisor, Clinical Research Scripps Cancer Center San Diego, California |
Beth S. Taubes, BSN, Director of Clinical Operations SHC-NY Consulting Services Inc. NYU Clinical Cancer Center New York, New York |
Download Activity
Download a Portable Document Format (PDF) version of Moving Ahead: Challenges With Combination Therapies for Colorectal Cancer (212 KB; Adobe Acrobat Reader 4.0 or higher is required).
Download References
Download a PDF version of the references cited in Moving Ahead: Challenges With Combination Therapies for Colorectal Cancer.
Download Chemotherapeutic Regimen Table
Download a PDF version of the Chemotherapeutic Regimen Table cited in Moving Ahead: Challenges With Combination Therapies for Colorectal Cancer.
Instructions for Online Completion
To successfully complete this activity, you must read the entire newsletter, register, and submit your learning assessment and evaluation online, correctly answering 70% of the learning assessment questions. If you provide your e-mail address, you will receive an immediate e-mail notification with a link to your printable statement of credit. If you do not provide your e-mail address, your statement of credit will be mailed to you within 4 weeks.
To register and submit your learning assessment and evaluation form online, click here.
Provider and Supporter
|
||
|
Release and Termination Dates
Release: August 2004
CE available until: August 31, 2005
Target Audience
This educational activity is designed for oncology nurses who care for patients with colorectal cancer (CRC) who are being treated with combination chemotherapies.
Activity Rationale and Purpose
The recent emergence of multiple combination chemotherapeutic regimens for CRC has expanded the treatment options for patients. The increased treatment complexity and unique side effect profiles of new agents greatly affect care management systems and patient lifestyles. The purpose of this newsletter is to provide practical insights into the changing landscape of CRC treatment and the implications for patient education and nursing care.
Learning Objectives
After participating in this activity, nurses should be able to
- Differentiate among chemotherapeutic agents and combination regimens available for the treatment of CRC
- Identify psychosocial and quality of life issues with combination regimens for CRC
- List practical strategies for managing acute and long-term complications of combination regimens for the treatment of CRC
When choosing among continuing education activities, clinicians should select those that are appropriate for their educational needs. Participants in educational activities have the implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional effectiveness. Clinicians should reflect on this activity and its applicability to their own patient population, and then identify and implement appropriate practice changes.
Credit Information
Statements of Credit.—To access the learning assessment and
evaluation forms online, visit
http://www.meniscus.com/eval/crc-management/.
Participants who successfully complete this activity (including scoring at least
70% on the learning assessment and completing and submitting the evaluation
form) will be issued a statement of credit via
This activity for
1.5
contact hours is provided by the Meniscus Educational Institute, which is
accredited as a provider of continuing nursing education by the American Nurses
Credentialing Center’s Commission on Accreditation.
Accreditation refers to recognition of educational activities only and does not imply approval or endorsement of any product by the American Nurses Credentialing Center’s Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider No. 13164, for 1.5 contact hours.
Privacy Policy
Meniscus Limited is committed to protecting the privacy of users of our Web site. Please click here to review Meniscus Limited’s privacy policy.